Should You Buy Latch, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Latch, Inc. (LTCH) carries a solid Quality of Company rating of 6.7/10. Trading at $0.15, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 3 of 3 CirclFi valuation models project upside for Latch, Inc. (LTCH) at $0.15 — the model consensus leans bullish, with a Quality Score of 6.7/10 and Value-Trap risk of 53/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Latch, Inc. (LTCH) in 2026?
What Is the Bull Case vs the Bear Case for Latch, Inc. (LTCH)?
| Bull case — $0.54 target (+260.0%) | Bear case |
|---|---|
| According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $0.15 and the median fair value of $0.46 implies +205.1% upside potential. | No active model flags significant downside for LTCH. The Value Trap score of 53/100 still argues for some caution. |
| According to the CirclFi Deep Alpha Valuation Engine, the PWERM model targets a fair value of $0.54 (+260.0%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | |
| Industry tailwind: AI/ML integration could provide meaningful support for Latch, Inc.'s revenue and margin trajectory in the Software - Application space. |
How Does LTCH Compare to Its Software - Application Peers?
Valuation data pages: PAYD · LAW · GRAB · THRY · DSNY · KC · OMQS · RCT · SSNC · ADSK · PTC
Which Other Stocks Score Like LTCH on Quality?
Closest companies to LTCH’s Quality of Company score of 6.7/10, across all industries.
- HUN — Huntsman Corporation (QOC 6.7) · analysis
- VSAT — Viasat, Inc. (QOC 6.7) · analysis
- LEGN — Legend Biotech Corporation (QOC 6.7) · analysis
- BCYC — Bicycle Therapeutics plc (QOC 6.7) · analysis
- SWAG — Stran & Company, Inc. (QOC 6.7) · analysis
- TEVA — Teva Pharmaceutical Industries Limited (QOC 6.7) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Software - Application Screens Does LTCH Appear In?
So Is Latch, Inc. (LTCH) Worth Buying in 2026?
Latch, Inc. at $0.15 presents what our engine identifies as a high-conviction opportunity: 3 of 3 models see upside, quality stands at 6.7/10, and the median fair value of $0.46 implies +205.1% return potential. Investors should verify this thesis against their own risk parameters and time horizon.
These are quantitative model outputs, not investment recommendations. Latch, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About LTCH Stock?
Should I buy LTCH stock right now?
Based on CirclFi's multi-model analysis, 3 of 3 models see upside for LTCH at $0.15. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.7/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Latch, Inc.?
Key risks include: an elevated Value Trap score of 53/100, suggesting apparent undervaluation may mask deteriorating fundamentals; limited model coverage (3/13 active), reducing analytical confidence; general market and sector-specific risks affecting Software - Application companies. Always diversify and consult a financial advisor.
How does LTCH compare to its competitors?
Among Software - Application peers, LTCH holds a Quality Score of 6.7/10. Comparable companies include PAYD (QOC 6.7), LAW (QOC 6.7), GRAB (QOC 6.8). The relative ranking helps investors identify whether LTCH offers better fundamental quality than alternatives in the same sector.
Is LTCH a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. LTCH's Quality Score of 6.7/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy LTCH at?
CirclFi does not provide target buy prices or price alerts. However, our 3 active models produce fair value estimates ranging from $0.34 to $0.54. At $0.15, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for LTCH.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad